HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeting of post-ischemic cerebral endothelium in rat by liposomes bearing polyethylene glycol-coupled transferrin.

Abstract
To achieve an efficient delivery targeting to post-ischemic cerebral vascular endothelium, PEG-liposome conjugated with transferrin (Tf) (Tf-PEG-liposome) was intravenously administered to the rats after 90 min of transient middle cerebral occlusion. The expression of Tf receptor (TfR) in the cerebral endothelium increased with a peak at 1 day after the reperfusion and returned to the control level by 6 days. The Tf-PEG fluorescence was marginally detectable in sham control brain, but remarkably increased with a peak at 2 days, showing about 70% of TfR positive vascular endothelium double-labeled with Tf-PEG. These results indicate that the Tf-PEG-liposome could be utilized as an efficient drug delivery tool to the brain after stroke.
AuthorsN Omori, K Maruyama, G Jin, F Li, S J Wang, Y Hamakawa, K Sato, I Nagano, M Shoji, K Abe
JournalNeurological research (Neurol Res) Vol. 25 Issue 3 Pg. 275-9 (Apr 2003) ISSN: 0161-6412 [Print] England
PMID12739237 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Liposomes
  • Receptors, Transferrin
  • Transferrin
  • Polyethylene Glycols
Topics
  • Animals
  • Blood-Brain Barrier
  • Brain Ischemia (drug therapy, metabolism)
  • Endothelium, Vascular (metabolism)
  • Infarction, Middle Cerebral Artery (metabolism)
  • Liposomes
  • Male
  • Polyethylene Glycols (administration & dosage)
  • Rats
  • Rats, Wistar
  • Receptors, Transferrin (biosynthesis)
  • Telencephalon (blood supply)
  • Transferrin (administration & dosage, metabolism, pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: